An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the distribution of a microbicidal gel in the vagina and confirm the
presence of bare spots. MRIs will be done with and without the addition of the MRI contrast
Gadolinium to the microbicide in order to determine whether the bare spots are an artifact of
the MRI technique.
Phase:
Phase 1
Details
Lead Sponsor:
Biosyn
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)